Revolutionizing orthopaedic surgery through evidence-based dignostics

JEDI is a Research to Business project funded by Business Finland to commercialize the research innovation from the Biomedical Spectroscopy Lab, University of Eastern Finland, Kuopio, Finland. The project’s mission will be to develop solutions that will revolutionize orthopaedic surgery through evidence-based diagnostics by enabling rapid and non-destructive diagnosis of tissue pathology without compromising workflows.

Our Mission

To equip surgeons with next-generation quantitative tools to enhance clinical outcomes in orthopaedic surgery

Join the mission

The Challenge

In joint surgery, surgeons are limited by current clinical approach for diagnosis of tissue pathology:

Subjective visual assessment

Unable to detect early-stage damage

Unreliable diagnosis

Our Solution

JEDl – a smart optical sensor that enables deep tissue and bone assessment in real-time beyond the surgeon’s visual reach

Accurate objective diagnosis

Early disease detection via assessment of molecular changes

Quantitative diagnostic scoring of tissue pathology (tissue quality index)

See the evidence

Our Product

JEDI

Our flagship product (JEDI) is an easy-to-use probe that enables the surgeon to diagnosis tissue intergrity in real-time based on near-infrared spectroscopy and machine learning.

Contact the team
JEDI

JEDI is an easy-to-use optical system that enables the surgeon to diagnosis tissue integrity in real-time based on near-infrared spectroscopy and machine learning.

Contact the team

Ergonomic

Design is similar to traditional arthroscopic hook for quick learning and easy adoption

Ergonomic

Design is similar to traditional arthroscopic hook for quick learning and easy adoption

Low latency

Real-time assessment with minimal extension of surgery time

Low latency

Real-time assessment with minimal extension of surgery time

Objective

Highly sensitive and specific assessment

Adjustable screen with a light
up screen edge indicator

The ergonomic JEDI probe
comes with a light indicator

Measurement is activated
through a foot pedal, ensuring
uncompromised hand
dexterity

Smart

Optical sensor combines photonics and AI for disease diagnosis

Stand-alone

No secondary device or attachment need

Stand-alone

No secondary device or attachment need

Multi-purpose

Assessment of cartilage, subchondral bone and meniscus during the same procedur

Multi-purpose

Assessment of cartilage, subchondral bone and meniscus during the same procedur

Easy to use

Smart and intuitive user interface for the OR

013_JEDI_UI concept_050923-06
013_JEDI_UI concept_050923-08
013_JEDI_UI concept_050923-04
013_JEDI_UI concept_050923-05

Latest news & publications

Show all

About us

JEDI is a Research to Business project funded by Business Finland to commercialize the research innovation from the Biomedical Spectroscopy Lab, University of Eastern Finland, Kuopio, Finland. The project’s mission will be to develop solutions that will revolutionize orthopaedic surgery through evidence-based diagnostics by enabling rapid and non-destructive diagnosis of tissue pathology without compromising workflows. The ultimate goal is to develop novel technologies to support clinicians in delivering optimal to enable better patient outcomes. Upon completion of the project, the optimal commercialisation pathway for JEDI to support objective assessment of tissue integrity during joint surgery will be determined and implemented.

The team

Contact the team
Isaac Afara

Associate Professor, PhD
BIOMEDICAL ENGINEERING

Project PI and expert in biospectroscopy. Background in Electrical (BSc. Hons.) and Biomedical (PhD) Engineering, with specific focus on biomedical instrumentation

Ervin Nippolainen

Docent, PhD
BIOPHOTONICS AND SPECTROSCOPY

Project manager and technology champion. Holds a PhD in optics, with expertise in design and development of optical instrumentation.

Teemu Haapala

MSc
BUSINESS AND MARKETING

Business champion. Holds an MSc in industrial design and has more than a decade experience in MedTech startups.

Awuniji Linus

MSc
BIOMECHANICS

Iman Kafian-Attari

MSc
COMPUTATIONAL MODELLING IN BIOPHOTONICS

Jari Torniainen

PhD
MACHINE LEARNING

Supported by

Clinical collaborators

Heikki Kröger
Jani Puhakka
Jussi Kosola
Harold Bromer

Testimonials

“Utilization of this instrument is easy, not only for equine but also for human surgeons”… “I strongly believe that JEDI makes the difference in such a way that not only the diagnosis of joint disease (i.e. articular cartilage damage) is more substantiated, but also the prognosis and the evaluation of regenerated cartilage tissue after repair surgery. I am convinced that an JEDI system will be part of the standard equipment ... during arthroscopic surgery in the near future”.
PROFESSOR HAROLD BROMMER
PROFESSOR HAROLD BROMMEREQUINE ORTHOPAEDIC SURGEON, UTRECHT UNIVERSITY, THE NETHERLANDS
regenerated cartilage tissue after repair surgery. I am convinced that an JEDI system will be part of the standard equipment ... during arthroscopic surgery in the near future”.
PROFESSOR HEIKKI KROGER
PROFESSOR HEIKKI KROGERCHIEF PHYSICIAN, KUOPIO UNIVERSITY HOSPITAL, FINLAND
“... I realized that the subjective visual assessment of cartilage (defect or repair) during arthroscopy is not reliable enough for research or clinical use. We need more objective and reliable methods to assess cartilage quality, and JEDI might be the solution for that.”
JANI PUHAKKA
JANI PUHAKKAORTHOPAEDIC SURGEON, HELSINKI UNIVERSITY HOSPITAL
Previous
Next

Research to Business Project Timeline

See full timeline
2020
2021
2023/24
2024/25
2025
1st gen. prototype
Ex-vivo validation
R2B funding
JEDI Pre-clinical test
Patent filing

Contact our team

Eager to hear more about our endeavours? Get in touch by filling in the form below:

Follow us on LinkedIn

JEDI is a Research to Business project funded by Business Finland to commercialize the research innovation from the Biomedical Spectroscopy Lab, University of Eastern Finland, Kuopio, Finland. The project’s mission will be to develop solutions that will revolutionize orthopaedic surgery through evidence-based diagnostics by enabling rapid and non-destructive diagnosis of tissue pathology without compromising workflows.

The ultimate goal is to develop novel technologies to support clinicians in delivering optimal to enable better patient outcomes. Upon completion of the project, the optimal commercialisation pathway for JEDI to support objective assessment of tissue integrity during joint surgery will be determined and implemented.